The alterations in multiple pathways such as WNT, prostaglandin-endoperoxide synthase 2 (PTGS2, also called as COX-2), EGF receptor (EGFR) and RAS are known to play a major role in CRC progression. Here, PTGS2 is linked to colorectal carcinoma.